
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A global biotherapeutics leader is seeking a Country Medical Lead in Singapore to execute the medical strategy and provide clinical guidance. This role requires a leader with a minimum of 7 years in the pharmaceutical industry, strong skills in team leadership, and a deep understanding of the therapeutic landscape. The candidate will engage with key stakeholders and ensure medical compliance while promoting ethical practices within the company. Join a dynamic team to deliver innovative therapies to patients in need.
The Country Medical Lead (CML) will be responsible for the delivery of the medical strategy plan and execution of scientific activities in Malaysia and Singapore. (referred to Country thereafter)
The CML will have overall responsibility for ensuring high quality scientific medical input and clinical strategic direction to support the Therapeutic Area teams to deliver growth in the Country.
The CML will provide and ensure medical expertise and guide medical strategy at country level, liaising with Cluster Lead, Global Medical Affairs and pro-actively collaborating cross functionally with multiple areas, including sales & marketing, market access, clinical development, pharmacovigilance and regulatory affairs.
The CML provides leadership to direct reports and wider medical affairs team, setting direction and ensuring team alignment while developing and retaining key talent.
The CML is responsible for increasing scientific credibility and the ethical image of CSL Behring, facilitating and encouraging the Group's product strategy.
The CML must promote, develop, and maintain strong scientific and medical relationships with TLs, Public Health Bodies and other stakeholders such as patient associations, scientific expert associations and regulatory authorities.
The CML will uphold the integrity of the company by being responsible for medical governance at the country level. This role will have responsibility for delivery on Medical Education.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .